* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Portfolio - TRG Communications, LLC Specializing in the Pharmabio
Human brain wikipedia , lookup
Donald O. Hebb wikipedia , lookup
Neurophilosophy wikipedia , lookup
NMDA receptor wikipedia , lookup
Node of Ranvier wikipedia , lookup
Selfish brain theory wikipedia , lookup
Haemodynamic response wikipedia , lookup
Brain Rules wikipedia , lookup
Axon guidance wikipedia , lookup
Neuroplasticity wikipedia , lookup
History of neuroimaging wikipedia , lookup
Cognitive neuroscience wikipedia , lookup
Psychoneuroimmunology wikipedia , lookup
Neural engineering wikipedia , lookup
Development of the nervous system wikipedia , lookup
Electrophysiology wikipedia , lookup
Neuropsychology wikipedia , lookup
Activity-dependent plasticity wikipedia , lookup
Signal transduction wikipedia , lookup
Aging brain wikipedia , lookup
Nonsynaptic plasticity wikipedia , lookup
Holonomic brain theory wikipedia , lookup
Metastability in the brain wikipedia , lookup
Single-unit recording wikipedia , lookup
Biology of depression wikipedia , lookup
Circumventricular organs wikipedia , lookup
Endocannabinoid system wikipedia , lookup
Synaptic gating wikipedia , lookup
Neuroregeneration wikipedia , lookup
Biological neuron model wikipedia , lookup
Synaptogenesis wikipedia , lookup
Neuromuscular junction wikipedia , lookup
Nervous system network models wikipedia , lookup
End-plate potential wikipedia , lookup
Clinical neurochemistry wikipedia , lookup
Chemical synapse wikipedia , lookup
Stimulus (physiology) wikipedia , lookup
Neuroanatomy wikipedia , lookup
Molecular neuroscience wikipedia , lookup
communications LLC Portfolio Campaign Development Training Materials and Medical Illustration Marketing Programs and Slide Presentations TRG Communications, LLC Rich Franco, President (m) 919.606.2908 (e) [email protected] communications LLC TRG Communications, LLC Rich Franco, President (m) 919.606.2908 (e) [email protected] communications LLC Campaign Development TESTOPEL® Turn It On FAMILION Family C-GAAP Gears Hylenex® recombinant REVEAL... www.trgcommunications.us | Rich Franco, President | (m) 919.606.2908 | [email protected] Campaign Development | TESTOPEL® Turn It On communications LLC Product: TESTOPEL® Client: Slate Pharmaceuticals, a division of Actient Pharmaceuticals Campaign: Turn It On Concept: TESTOPEL®, the only long-acting treatment for men with Low T. Once implanted (Turned On), men were spontaneously compliant with therapy. This feature would enable men to enjoy the benefits of testosterone therapy without the hassle of saw tooth T-levels while avoiding the daily hassle of administering a topical therapy. Creative: We used the universal “On” symbol (as seen on a multitude of devices used today) as highlight recognizable inconography to denote the patient being “Powered On” for 3-6 months once TESTOPEL® is placed. Select Materials Developed: Core sales aid, patient education materials, posters www.trgcommunications.us | Rich Franco, President | (m) 919.606.2908 | [email protected] Campaign Development | FAMILION Family communications LLC Product: FAMILION, family of genetic tests for inherited cardiac diseases Client: PGxHealth, Transgenomic Campaign: Family Concept: Inherited cardiac diseases represent an unsuspecting risk to the families they affect. FAMILION represents an opportunity to make the unknown risk known so it can be treated and/or tracked through at-risk families. Creative: Tie together real life family scenes with pedigree graphic to illustrate the existence of the unknown risk. Select Materials Test kit, core sales aid for channelopathies and cardiomyopathies, patient Developed: and family education www.trgcommunications.us | Rich Franco, President | (m) 919.606.2908 | [email protected] Campaign Development | C-GAAP Gears communications LLC Product: C-GAAP Genetic Test for Clopidogrel Response Client: Transgenomic Campaign: Gears Working Together Concept: The C-GAAP Clopidogrel Response Test was the only genetic test to include CYP2C19 and ABCB1, thus there were two genes that worked synergistically to predict a patient’s response to clopidogrel. We developed a well understood graphic to illustrate why it was important to genotype both genes as opposed to just CYP2C19. Creative: Each gear represents one of the genes included as part of the test. Graphically this illustrated that both genes ultimately impact the metabolism or absorption of clopidogrel. Select Materials Developed: Core sales aid www.trgcommunications.us | Rich Franco, President | (m) 919.606.2908 | [email protected] Campaign Development | Hylenex® recombinant REVEAL... communications LLC Product: Hylenex® recombinant (hyaluronidase human injection) Client: Halozyme Therapeutics Campaign: REVEAL… Concept: Most clinicians were unaware of which hyaluronidase they were using. It was time that they had the source of each version of hyaluronidase revealed. Hylenex® recombinant is the only recombinant human hylauronidase available. Despite being the only recombinant human hyaluronidase, it was priced at a discount to the other FDA-approved product on the market. Creative: Hyaluronidase is most commonly used as part of an anesthetic regimen administered prior to various ocular surgeries. The brightly colored eye with a DNA strand simply reiterates that when doctors use Hylenex® recombinant they are using the only recombinant human FDA-approved hyaluronidase available. Select Materials Developed: Sales Aid, Tabletop Panels www.trgcommunications.us | Rich Franco, President | (m) 919.606.2908 | [email protected] communications LLC Training Materials & Medical Illustration Viibryd™ 7 Module Learning System Hylenex® recombinant Infusion Illustrations www.trgcommunications.us | Rich Franco, President | (m) 919.606.2908 | [email protected] Training Materials & Medical Illustration communications LLC Viibryd™ 7 Module Learning System Product: Viibryd™ (vilazadone HCl) Client: Trovis Pharmaceuticals Material: 7 module learning system with original illustrations Background: Trovis was posed to launch a novel antidepressant into a very crowded market. We were asked to develop a written set of training materials that could then be incorporated into a web based training program. The materials developed included disease background, market background, competitors, About Viibryd and Objection Handling modules. All illustrations and copy were produced in-house. Full module example included at the end of this PDF. www.trgcommunications.us | Rich Franco, President | (m) 919.606.2908 | [email protected] communications Training Materials & Medical Illustration LLC Hylenex® Recombinant Infusion Illustrations Product: Hylenex® recombinant for use with insulin pumps Client: Halozyme Material: Patient Instruction sheets featuring original medical illustrations Background: As part of preparing for potential commercialization of Hylenex recombinant for use with insulin pumps, a series of patient instructions for use needed to be created. We were asked to develop original medical illustrations depicting several different infusion sets. Our goal was to be medically accurate but as patient-friendly as possible. All illustrations and copy were produced in-house. Vial Adapter/ Connector Package Vial Cannula End of Tubing Vial Cap Syringe Package Vial Adapter/Connector Syringe Plunger Luer Lock Tubing Package Cannula Housing (not included) www.trgcommunications.us | Rich Franco, President | (m) 919.606.2908 | [email protected] communications LLC Marketing Programs & Slide Presentations TESTOPEL® Patient Rebate Program FAMILION Family Slide Presentation Transgenomic Capital Campaign www.trgcommunications.us | Rich Franco, President | (m) 919.606.2908 | [email protected] communications Marketing Programs & Slide Presentations LLC TESTOPEL® Patient Rebate Program Product: TESTOPEL® Program: TESTOPEL® Patient Rebate Program Client: Slate Pharmaceuticals, a division of Actient Pharmaceuticals Background: TESTOPEL is most commonly purchased and billed by clinicians, retail pharmacy visit as few. Slate Pharmaceuticals wanted to offer a rebate to patients. We developed the entire rebate process and oversaw the execution of the program with our fulfillment partner. The goal was to be compliant with all laws governing rebate programs and appropriate based upon regulatory/medical review. Materials: Clinician/staff education materials, patient enrollment/education materials and all fulfillment materials (check and letter), weekly status reports, patient survey TES-M1051 NO POSTAGE NECESSARY IF MAILED IN THE UNITED STATES 01/13 BUSINESS REPLY MAIL FIRST-CLASS MAIL PERMIT NO. 626 CHAPEL HILL, NC POSTAGE WILL BE PAID BY ADDRESSEE TESTOPEL Patient Rebate Program Headquarters c/o Beechwood Associates PO Box 1190 Morrisville, NC 27560 USPS BRM Template #10 Envelope 4-1/8" x 9-1/2" Working Layer January 2001 File Name: b10.pdf www.trgcommunications.us | Rich Franco, President | (m) 919.606.2908 | [email protected] Marketing Programs & Slide Presentations communications LLC FAMILION Family Slide Presentation Product: FAMILION, family of genetic tests for inherited cardiac diseases Slide Presentation: FAMILION Slides Client: PGxHealth, Transgenomic Background: We were asked to create a multi-module professional slide presentation that doctors or nurses could use to present to either other HCPs or patients. Shown here are the first several slides of one of the presentation decks. Materials: Slide decks were assembled for each disease state for which there was a FAMILION test. www.trgcommunications.us | Rich Franco, President | (m) 919.606.2908 | [email protected] Marketing Programs & Slide Presentations communications LLC Transgenomic Capital Campaign Product: Transgenomic Company Slide Presentation Slide Presentation: Transgenomic Capital Campaign Client: PGxHealth, Transgenomic Background: We were asked to work with senior leadership at Transgenomic to assemble a slide presentation intended to raise capital. The presentation had to represent each one of Transgenomic’s business units and clearly articulate the unique value it represented. Shown here are the first several slides of the presentation deck. www.trgcommunications.us | Rich Franco, President | (m) 919.606.2908 | [email protected] Module • 2 The Central Nervous System and Pathophysiology of Major Depressive Disorder (MDD) CONFIDENTIAL For Internal Use Only. The information contained in this training module is for educational purposes only. It is designed to provide you with the information you need to be educated on the product, disease and competitive environment and is not to be distributed or used in detailing. 2 CONFIDENTIAL: For Internal Use Only. 2 2 Table of Contents Chapter 1: Theories About the Causes of MDD................................................3 1.1. Theories About the Causes of MDD....................................................................................3 1.2. Select Emotions, Behaviors and Bodily Functions Regulated by Neurotransmitters..........................................................................................5 Chapter 2: The Central Nervous System..............................................................7 2.1. Regions of the Brain...................................................................................................................7 2.2. Spinal Cord.................................................................................................................................10 2.3. Peripheral Nervous System..................................................................................................10 2.4. Summary of Central Nervous System..............................................................................11 Chapter 3: Neuroanatomy Related to MDD.................................................... 13 3.1. The Neuron................................................................................................................................13 3.2. Neurotransmission..................................................................................................................14 3.3. Neurotransmitters, Receptors and Ion Channels......................................................... 16 3.3.1. Neurotransmitters.......................................................................................................16 3.3.2. Ion Channels.................................................................................................................17 3.3.3. Receptors........................................................................................................................18 3.4. Biochemical Theory of Depression....................................................................................19 Brain Booster............................................................................................................... 21 Definitions..................................................................................................................... 23 References..................................................................................................................... 25 Learning Objectives Review theories of the causes of MDD. Review the neurotransmission process. Review neuroanatomic structures associated with MDD. Describe different neurotransmitters associated with MDD. Understand how the dysregulation of neurotransmitters may occur. 1 CONFIDENTIAL: For Internal Use Only. 2 Chapter 1: Theories on the Causes of MDD The exact cause of depression is unknown; however, the vast majority of health care professionals accept the biochemical theory as the preeminent cause of depression. To have a successful discussion with a health care professional about MDD you must have a solid working knowledge of the central nervous system (CNS) and the role of neurotransmitters. The theories of the cause of depression outlined in Table 1 are not mutually exclusive. For example, researchers might discover a link between the biochemical and heredity theories in which a genetic polymorphism(s) may better predict people at increased risk of developing depression. 1.1. Theories About the Causes of MDD The exact cause of depression is unknown; however, the vast majority of health care professionals accept the biochemical theory as the pre-eminent cause of depression. Table 1: Theories of the Cause of Depression Theory Description Biochemical Theory Dysfunction of neurotransmitters (serotonin, norepinephrine, dopamine) in the brain are thought to be responsible for causing depression. Psychological Theories Factors such as low self-esteem, harsh superego, and dependent personalities account for most depression. Social Theories Life events and stress cause depression. Heredity/genetic Theories Some evidence exists that suggests a specific gene or genes might be responsible for depression. Integrative Theory Depression involves biological, experiential and behavioral components; factors such as biological vulnerability and physiological and psychosocial stressors all contribute to depression. None of these theories provides a singular explanation for all MDD. However, the mechanism of action of antidepressants lends support to the belief that the biochemical theory is the most appropriate explanation for most MDD. 3 2 2 Chapter 1: Theories on the Causes of MDD The relationship between the effect of neurotransmitters on the brain and body is often referred to as the mind-body link. Figure 1 and several other sections of this module serve to explain the roles of neurotransmitters in depression. Figure 1: Dysregulation of Serotonin (5-HT) is Believed to be the Primary Cause of MDD1,2,3,4 Dysregulation of 5-HT (serotonin) is strongly associated with MDD. 5-HT (serotonin) and other neurotransmitters help modulate certain bodily functions via the descending pathway. CONFIDENTIAL: For Internal Use Only. 4 2 2 Neurotransmitters are chemical substances that transmit nerve impulses. 1.2. Select Emotions, Behaviors and Bodily Functions Regulated by Neurotransmitters Neurotransmitters are chemical substances that transmit nerve impulses. Key neurotransmitters, like serotonin, originate in the midbrain and project to various locations throughout the human nervous system. Within the brain, neurotransmitters help mediate numerous emotional and behavioral functions. A brief list of emotions and/or behaviors regulated by neurotransmitters is shown below. For MDD patients certain neurotransmitters may dysfunction and result in an inability to regulate emotions and/or behaviors. Sadness Anxiety Irritability Pleasure Guilt Concentration Appetite Sexual function Projections from the brain stem descend down the spinal cord where they have a role in helping to regulate certain bodily functions. A brief list of these functions is shown below. Vasoconstriction Urethral sphincter contractions Bladder wall relaxation Gastrointestinal motility Pilomotor contraction (goose bumps) Normally, the sensations associated with the routine functioning of the body, such as digestion in the abdomen, urogenital function, and/or routine inputs to the musculoskeletal system throughout the body, are suppressed from our awareness so that attention can be paid to events occurring outside of the body and the central nervous system can react appropriately. 5 CONFIDENTIAL: For Internal Use Only. 6 2 2 Chapter 2: The Central Nervous System Together, the spinal cord and brain are known as the central nervous system (CNS). The CNS acts as the control center of the entire nervous system, interpreting incoming information and issuing responses. 2.1. Regions of the Brain As shown in Figure 2, the brain has the following major regions: Cerebrum Cerebellum Diencephalon (thalamus & hypothalamus) Brainstem Figure 2: The Major Regions of the Human Brain Cerebrum Diencephalon (thalamus & hypothalamus) Cerebellum Midbrain Pons Brainstem Medulla Oblongata Spinal Cord The cerebrum is the largest region of the brain. It controls voluntary motor functions; coordinates physical, sensory, visual and auditory sensations; and integrates consciousness, memory, use of language, and emotions. 7 Chapter 2: The Central Nervous System Human emotion involves the entire nervous system, but there are two parts of the CNS that are especially important: the limbic system and the autonomic nervous system. The surface of the cerebrum is called the cerebral cortex and is composed of six layers. It is made of gray matter, which is also found in the other parts of the nervous system. Because this gray matter enlarges more than the rest of the brain during development, it rolls and folds upon itself to produce convolutions (also known as gyri), fissures and sulci. The most prominent fissure separates the cerebrum into 2 halves—the right and left hemispheres of the brain. The interior of the cerebrum, underneath the cerebral cortex, is known as the white matter. It consists mainly of the axons of neuronal cells connecting different regions of the cortex and the cortex with other parts of the brain and spinal cord. The cerebellum, the second largest region of the brain, functions to control skeletal muscles, primarily in terms of coordination and balance. Human emotion involves the entire nervous system, but there are two parts of the CNS that are especially important: the limbic system and the autonomic nervous system. The limbic system is a complex set of structures that lies on both sides of the thalamus, just under the cerebrum. It includes the diencephalon (thalamus and hypothalamus), the hippocampus, the amygdala, and other nearby areas (see Figure 3). It is primarily responsible for our emotional life, and the formation of memories. The thalamus coordinates all sensory impulses, except for the sense of smell. It also plays a role in emotions by associating sensory impulses with feelings of pleasantness and unpleasantness. The hypothalamus controls many body activities, and it is one of the major regulators of homeostasis in the brain. It also serves as a link between the nervous system and the endocrine system. The hypothalamus modulates human urges, such as eating, drinking and sexual arousal, as well as emotional and behavioral patterns. The brainstem includes the medulla oblongata, pons and midbrain. These areas regulate autonomic (involuntary) behaviors, including respiration, cardiac function and vasomotor functions. CONFIDENTIAL: For Internal Use Only. 8 2 2 Table 2: Functions of Major Brain Regions Region Function · · · Controls voluntary motor functions. Cerebellum · Controls skeletal muscles primarily in coordination and balance. Diencephalon · Thalamus coordinates all sensory impulses except for olfaction, including those for touch, pain and temperature. Also associates sensory impulses with feelings of pleasantness and unpleasantness. · The hypothalamus controls many body activities, and it is one of the major regulators of homeostasis in the brain; also serves as a link between the nervous system and the endocrine. · · Composed of medulla oblongata, pons and midbrain. Cerebrum Brainstem Coordinates physical, sensory, visual and auditory sensations. Integrates consciousness, memory, use of language and emotions. Controls involuntary processes; regulates respiration, cardiac function, vasomotor functions, and facial nerve reflexes. Figure 3: The Limbic System Cingulate cortex Cerebrum Fornix Mammillary body Thalamus Diencephalon Amygdala (thalamus & hypothalamus) Hippocampus Pituitary Gland Midbrain Cerebellum Pons Medulla oblongata Spinal cord 9 Brainstem Chapter 2: The Central Nervous System Thirty-one pairs of spinal nerves emerge from the spinal cord, these serve as a means of neurotransmitter projection to the peripheral nervous system. 2.2. Spinal Cord The spinal cord is protected by the vertebral column as well as the meninges, which also surround the brain. The gray matter of the spinal cord is shaped like the letter H. It is made up of the cell bodies of neurons and unmyelinated axons and dendrites. Thirty-one pairs of spinal nerves emerge from the spinal cord, these serve as a means of neurotransmitter projection to the peripheral nervous system. 2.3. Peripheral Nervous System The peripheral nervous system includes all nerves external to the CNS. These include the cranial and spinal nerves that emerge from and enter the CNS, and their terminal projections—the axon terminals that synapse with muscle fibers, glands, or other cells stimulated by nerves. These peripheral nerves relay impulses between the sense organs, the CNS, and muscles and glands throughout the body. Overall, the peripheral nervous system gathers information from the periphery, routes it to the CNS for interpretation, and then transmits a response from the CNS back to the periphery. The peripheral nervous system may be further subdivided into: The somatic (voluntary) nervous system The autonomic (involuntary) nervous system, which is further divided into sympathetic and parasympathetic branches CONFIDENTIAL: For Internal Use Only. 10 2 2 Malfunctioning neurotransmitters can cause illnesses like MDD, GI upset and urinary incontinence. 2.4. Summary of the Central Nervous System Figure 4 summarizes information presented to this point and provides an aggregate view of the CNS. Neurotransmitter regulation is essential to the central nervous system functioning properly. Malfunctioning neurotransmitters can cause illnesses like MDD, GI upset and urinary incontinence. Figure 4: The Central Nervous System Nervous system Central nervous system (CNS) Peripheral nervous system (PNS) Brain Input Output Spinal Cord Somatic (voluntary) Autonomic (involuntary) Sympathetic Skeletal muscle, such as the facial muscles, and the muscles found in the limbs, such as the biceps and triceps. 11 Parasympathetic Cardiac muscle, smooth muscle and glands. CONFIDENTIAL: For Internal Use Only. 12 Chapter 3: Neuroanatomy Related to MDD 3.1. The Neuron The neuron, or nerve cell, is the basic functional unit of all nervous system tissue. As shown in Figure 5, all neurons contain the same basic features: Cell Body Dendrite Axon The cell body contains the nucleus and other organelles that carry out the processes that maintain the life of the cell. Each neuron has one or more dendrites, which are highly branched extensions that receive nerve signals from other neurons and conduct these signals to the cell body. Each neuron also has at least one axon, a tubular extension that carries nerve impulses away from the cell body toward other neurons. Each axon ends in many fine branches that have specialized endings called terminals, the regions at which neurons actually transmit impulses to other neurons. Surrounding the axons of many neurons is a fatty substance called myelin. The myelin sheath insulates the axons and increases the transmission rate of impulses and is formed by specialized cells that wrap themselves around axons. Figure 5: Neuron Structures Cross section Dendrites Myelin Sheath Axon Nucleus Cell body Myelin Axon terminals Organelles 13 2 2 Chapter 3: Neuroanatomy Related to MDD To be transmitted from neuronto-neuron, the electrical charge must be translated into a chemical signal, called neurotransmitters, which cross the synaptic cleft. 3.2. Neurotransmission Information is transmitted along a neuron by means of a moving electrical charge. This electrical charge must then be transmitted to the next neuron across a gap known as the synaptic cleft. To be transmitted from neuron-to-neuron, the electrical charge must be translated into a chemical signal, called neurotransmitters, which cross the synaptic cleft. Once across the synaptic cleft the chemical signal reverts back to an electrical signal. The complete juncture between an axon terminal and another cell is known as the synapse. The synapse consists of the surface of the axon terminal, known as the presynaptic surface, and a postsynaptic surface, which is most often the dendrite of an adjoining cell. As shown in Figure 6, there are receptors and ion channels on both the presynaptic and postsynaptic surfaces. Figure 6: Synapse Structure Presynaptic surface Presynaptic neuron Vesicles containing neurotransmitters Neurotransmitters Synaptic cleft Receptors/ Ion channels Postsynaptic neuron Postsynaptic surface Figure 7 illustrates the basic sequence of events that occur in neurotransmission. Synaptic vesicles containing neurotransmitters are located in the axon terminal of the presynaptic neuron. When triggered by an electrical impulse, ion channels in the presynaptic membrane open, allowing calcium ions (Ca2+) to flow into the cell. This influx of Ca2+ causes the vesicles to release the stored neurotransmitters into the synaptic cleft. The neurotransmitters diffuse across the synaptic cleft and bind to specific receptors on the postsynaptic membrane. This binding causes ion channels in the postsynaptic membrane to open or close. Depending on the type of ion channel and the ions that move into or out CONFIDENTIAL: For Internal Use Only. 14 2 2 Each neuron may receive impulses from many other neurons, some excitatory and some inhibitory, therefore the behavior of a neuron is determined by the sum of the incoming impulses it receives. For patients with MDD, neurotransmitters may be reabsorbed by the presynaptic terminal in a process known as reuptake. Many classes of antidepressants, including the SSRIs, are believed to relieve the symptoms of depression by blocking the reuptake of serotonin by the presynaptic neuron. of the cell, the cell is either activated and propagates the electrical signal, or inhibited from propagating the signal. Each neuron may receive impulses from many other neurons, some excitatory and some inhibitory, therefore the behavior of a neuron is determined by the sum of the incoming impulses it receives. Figure 7: Neurotransmission 1 Action potential in nerve terminal opens Ca2+ channels 2 3 Presynaptic axon terminal Receptor/ ion channel Neurotransmitters cross synaptic cleft and bind to receptors Ca2+ entry causes vesicles to release neurotransmitters Neurotransmitters Ca2+ Ca2+ Ca2+ Ca2+ Ca2+ Ions 4 5 Ion channels open, ions enter the postsynaptic cell Postsynaptic cell Cell is either activated and propagates signal or signal is inhibited The binding of a neurotransmitter to a receptor is reversible. When the complex formed between the neurotransmitter and the receptor dissociates, both neurotransmitter and receptor are free to function again. Neurotransmitters crossing the synaptic cleft and binding to a postsynaptic receptor is not the only thing that can occur when neurotransmitters are released from the presynaptic neuron. For patients with MDD, neurotransmitters may be reabsorbed by the presynaptic terminal in a process known as reuptake. Specific pumps in the membrane of the presynaptic cell carry neurotransmitter molecules from the synaptic cleft back into the axon terminal. Once in the axon terminal, the neurotransmitters are either reincorporated into vesicles or broken down by enzymes. Two other alternatives are that the neurotransmitters released into the synaptic cleft may diffuse away or be enzymatically broken down. Many classes of antidepressants, including the SSRIs, are believed to relieve the symptoms of depression by blocking the reuptake of serotonin by the presynaptic neuron. 15 Chapter 3: Neuroanatomy Related to MDD The roles and actions of neurotransmitters, the receptors they bind to, and the ion channels they activate are interrelated. 3.3. Neurotransmitters, Receptors and Ion Channels The roles and actions of neurotransmitters, the receptors they bind to, and the ion channels they activate are interrelated. 3.3.1. Neurotransmitters As mentioned, functional neurotransmitters are chemical compounds carried through neurons in vesicles and are intended to bind to post-synaptic neuron receptors. There are several different groups of neurotransmitters, as listed in Table 3. Table 3: Summary of Key Neurotransmitters in MDD Neurotransmitter Origin Associated Effects Serotonin (5-HT) Raphe Nuclei Mood, emotional behavior, sleep, memory, appetite, sexual functioning, painful physical symptoms Norepinephrine (NE) Locus Ceruleus Mood, emotions, cognition, attention, anxiety, lack of energy, vigilance, sweating, painful physical symptoms Dopamine (DA) Midbrain Body motion, motivational drive, muscle coordination It was once believed that each neuron contained only a single type of neurotransmitter, and the neuron was named after the neurotransmitter it contained. For example, neurons containing serotonin would have been known as serotonergic neurons. Now it is known that many neurons may contain at least 2 neurotransmitters. Table 3 also shows the emotions or biological functions mediated by the three primary neurotransmitters associated with MDD. CONFIDENTIAL: For Internal Use Only. 16 2 2 3.3.2. Ion Channels Ion channels and receptors both reside on the postsynaptic cell. Ion channels are gated pores spanning the cell membrane. By changing the electrical charge on both sides of the membrane, ion channels play a key role in propagating a nerve impulse. Ion Channels: Open and close like a gate in response to specific signals. Recognize specific ions and only allow the ions to pass through them when the pores are open. Ion channels are quite selective for the ions they allow to pass through them. For example, there are specific channels each for potassium (K+), sodium (Na+), calcium (Ca2+), and Chloride (Cl-), among others. Each ion channel is associated with a different type of receptor. Thus, one type of Ca2+ channel may be regulated by one neurotransmitter receptor subtype, while another type of Ca2+ channel may be regulated by a receptor subtype for a different neurotransmitter. Figure 8: Ion Channel Cl - Cl- Cl- Pore Cell membrane Extracellular Intracellular Gate Cl- ClCl - ClCl- ClClNerve impulse propagation 17 Chapter 3: Neuroanatomy Related to MDD Postsynaptic receptors act to regulate the propagation or inhibition of the impulse in the postsynaptic cell. 3.3.3. Receptors Receptors are complex proteins with special configurations that allow specific molecules, such as neurotransmitters or drugs, to bind with them. Understanding the interaction between neurotransmitter receptors and their biologic function upon drug binding is very important when discussing MDD and the various drug classes used to treat MDD. Most psychoactive are either receptor agonists or antagonists. These terms relate to their effect upon the receptor. This binding may modify the receptor’s behavior and leads to one of the following changes: Receptor agonism – A drug or neurotransmitter binds to a specific cell receptor and triggers a response by the cell. The response triggered is often the cell’s natural biologic function. Receptor antagonism – A drug binds to a specific cell receptor and blocks it from performing a specific biologic function. Figure 7 in this module illustrates that neurotransmitter receptors are located on both the presynaptic and postsynaptic cell surfaces. Presynaptic receptors primarily act to regulate the release of neurotransmitters from that neuron. Postsynaptic receptors act to regulate the propagation or inhibition of the impulse in the postsynaptic cell. CONFIDENTIAL: For Internal Use Only. 18 2 2 The biochemical theory suggests that depression is the result of a neurochemical imbalance or a functional deficiency of one or more key neurotransmitters. 3.4. Biochemical Theory of Depression While no single theory explains all MDD, the biochemical theory is widely accepted. The biochemical theory suggests that depression is the result of a neurochemical imbalance or a functional deficiency of one or more key neurotransmitters. While 5-HT is most commonly associated with MDD both norepinephrine and dopamine are also believed to influence depression. The biochemical theory is based on the following observations: Drugs that promote the augmentation of these key neurotransmitters, especially 5-HT, can alleviate depressive symptoms. Drugs that impede the activity of these neurotransmitter systems (e.g., antihypertensives) can induce depression. Autopsy data have shown low concentration of neurotransmitters in the brains of suicidal and/or depressed patients. Concentrations of neurotransmitters also tend to be lower in the cerebrospinal fluid (CSF) and the peripheral blood of depressed patients. 19 CONFIDENTIAL: For Internal Use Only. 20 2 2 Brain Booster Brain Booster – Prepare for your online quiz. Module 2 certification requires a score of ≥85%. These questions should help you prepare. 1. List the 5 theories of the cause of depression and the circle the one that is most accepted. 2. What is the name of the group of areas within the brain are responsible for our emotional health? A. Cerebellum 3. B. Cerebrum C. Limbic System D. Hypothalamus What is a neurotransmitter carried within in the presynaptic neuron? A. Lipoprotein B. Versicle C. Dopamine D. Receptor 4. List the neurotransmitters associated with depression. 5. Drugs have one of two effects on receptors, name their potential effects and describe each: 21 Brain Booster 6. What is the basic functional unit of the human nervous system? A. Ion Channel B. Receptor C. Neuron D. None of these 7. The following process is described as an electrical charge being transmitted to the next neuron across synaptic cleft. A. Antagonism B. Agonism C. Neurotransmission D. None of these 8. The diencephalon contains what two portions of the brain important to human emotion and memory creation? A. Cerebellum and Hypothalamus B. Brain Stem and Thalamus C. Hypothalamus and Thalamus D. None of these CONFIDENTIAL: For Internal Use Only. 22 2 2 Definitions Afferent Neuron: A neuron that carries impulse toward the CNS. Autonomic Nervous System: Part of the nervous system that regulates activity of smooth muscle, cardiac muscle and glands. Axon: A tubular extension that carries nerve impulses away from the cell body toward other neurons. Brainstem: Stalklike portion of the brain connecting cerebral hemispheres with the spinal cord; controls involuntary process such as respiration. Central Nervous System (CNS): One of the two main divisions of the nervous system, consisting of the brain and the spinal cord. Cerebellum: The second largest region of the brain; functions to control skeletal muscles primarily in coordination and balance. Cerebrum: Largest region of the brain; controls voluntary motor functions; coordinates physical, sensory, visual and auditory sensations; integrates consciousness, memory, use of language and emotions. Cortex: The convoluted layer of gray matter covering each cerebral hemisphere. Dendrite: Highly branched extensions that receive nerve signals from other neurons and conduct these signals to the cell body. Diencephalon: Portion of the brain that contains the thalamus and the hypothalamus. Dorsal Horn: Crescent-shaped projection of gray matter in spinal cord. Efferent Neuron: Nerve fibers that carry impulses outward, away from the brain and spinal cord. Fissures: The deep grooves between folds of brain tissue. Gray Matter: Those regions of the brain and spinal cord that are made up primarily of the cell bodies and dendrites of nerve cells, rather than myelinated axons. Gyri: Prominent rounded elevations of brain tissue that form the cerebral hemispheres. Homeostasis: A state of equilibrium or a tendency to reach equilibrium, either metabolically within a cell or organism or socially and psychologically within an individual or group. Hypothalamus: Brain region primarily involved in autonomic (involuntary) nervous system functions, hormone secretion, and mood; major regulatory of homeostasis. Limbic System: A group of neuronal pathways that connect parts of the cerebrum, diencephalon and brainstem. Midbrain: Also called mesencephalon; the short part of the brainstem just above the pons; the center for visual reflexes. Medulla Oblongata: The base of the brain, which is formed by the enlarged top of the spinal cord; directly controls breathing, blood flow, and other essential functions. Meninges: The 3 membranes enclosing the brain and the spinal cord, comprising of the dura matter, the pia matter and the arachnoid membrane. 23 Definitions Myelin Sheath: A fatty substance that insulates the nerve fiber and helps to speed nerve impulse transmission. Neurochemical: Pertaining to chemicals involved in nervous system function. Neurotransmitter: Chemical substance that enables communication between nerve cells. Noradrenergic: Using norepinephrine as a neurotransmitter, norepinephrine is also called noradrenaline. Norepinephrine (NE): Neurotransmitter widely distributed throughout the nervous system; involved in regulating sleep, wakefulness, learning, memory and mood. Nucleus: An organelle that is the location of the genetic material of the cell. Organelles: A specialized part of a cell that has its own function . Parasympathetic Nervous System: A branch of the autonomic nervous system; slows the heart rate, increases the intestinal and gland activity, and relaxes the sphincter muscle. Pons: A prominence on the ventral (front) surface of the brainstem, between the medulla oblongata and the midbrain. Presynaptic Neuron: Nerve cell that transmits the signal across the synaptic cleft by releasing neurotransmitters. Postsynaptic Neuron: Nerve cell that receives the signal transmitted across the synaptic cleft. Serotonergic: Using serotonin as a neurotransmitter. Serotonin (5-HT): Neurotransmitter found in many regions of the brain and other parts of the body; involved in the regulation of mood, emotional behavior, sleep, memory and appetite, as well as modulation of the dopamine system. Somatic Nervous System: Part of the peripheral nervous system that allows for interaction with the external environment; composed of afferent and efferent neurons. Sulci: Grooves or furrows on the surface of the brain, bounding the several convolutions, or gyri. Sympathetic Nervous System: Branch of the autonomic nervous system that accelerates the heart rate, constricts blood vessels, and raises blood pressure. Synapse: The junction between an axon terminal and another neuron. Synaptic Cleft: The space between the presynaptic and postsynaptic surfaces. Thalamus: Brain region located above midbrain; relays sensory information to the cerebral cortex. Transmission: The process of movement of nerve impulse along neural pathways in the body. White Matter: Bundles of myelinated axons located in the brain and spinal cord. CONFIDENTIAL: For Internal Use Only. 24 2 2 References 1. Fields H. Depression and pain: A neurobiological model. Neuropsychiatry Neuropsychol Behav Neurol. 1991;4(1):83-92. 2. Bair MJ,Robinson RL,Katon W,Kroenke K. Depression and pain comorbidity. Arch Intern Med. 2003;163:2433-2445. 3. Blier P, Abbott FV. Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain. J Psychiatry Neurosci. 2001;26(1):37-43. 4. Nitti VW. Duloxetine: a new pharmacologic therapy for stress urinary incontinence. Rev Urol. 2004;6(suppl 3):S48-S55 25 Copyright © 2011 Trovis Pharmaceuticals. VIL-AMT-015 02/2011 2 CONFIDENTIAL For Internal Use Only. The information contained in this training module is for educational purposes only. It is designed to provide you with the information you need to be educated on the product, disease and competitive environment and is not to be distributed or used in detailing.